Vitamin D and Cardiovascular Risk: Which Implications in Children?
Open Access
- 16 May 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (10), 3536
- https://doi.org/10.3390/ijms21103536
Abstract
Vitamin D (25OHD) pleiotropic effects are widely recognized and studied. Recently, vitamin D cardiovascular effects are gaining interest, especially in children, although the studies present conflicting data. Some randomized controlled trials (RCTs) have demonstrated that cardiovascular risk markers, such as lipid parameters, inflammation markers, blood pressure, and arterial stiffness, are unaffected by vitamin D supplementation. By contrast, other studies show that low vitamin D levels are associated with higher risk of cardiovascular disease (CVD) and mortality, and support that increased risk of these diseases occurs primarily in people with vitamin D deficiency. An update on these points in pediatric patients is certainly of interest to focus on possible benefits of its supplementation.This publication has 87 references indexed in Scilit:
- Vitamin D Deficiency Induces High Blood Pressure and Accelerates Atherosclerosis in MicePLOS ONE, 2013
- Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysisThe American Journal of Clinical Nutrition, 2012
- The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implicationsInternational Journal of Obesity, 2011
- 1,25-Dihydroxyvitamin D3 suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activationArchives of Biochemistry and Biophysics, 2011
- A role for the cell cycle phosphatase Cdc25a in vitamin D-dependent inhibition of adult rat vascular smooth muscle cell proliferationThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- 20-Hydroxycholecalciferol, Product of Vitamin D3 Hydroxylation by P450scc, Decreases NF-κB Activity by Increasing IκBα Levels in Human KeratinocytesPLOS ONE, 2009
- 1,25-Dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoterAtherosclerosis, 2009
- Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressureThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin systemJCI Insight, 2002
- Clinical and echocardiographic disease in patients starting end-stage renal disease therapyKidney International, 1995